Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-08-21 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
独立董事关于第五届董事会第三十四次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding a specific board meeting (the 34th temporary meeting of the 5th board). It discusses the use of idle funds for cash management and confirms compliance with relevant laws and company articles. There is no financial data, no annual or quarterly report content, no earnings release, no voting results, no management changes, and no regulatory certification. The document is a board/management related opinion on a board meeting matter, which fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report but an opinion statement from directors.
2023-08-21 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 盈康生命科技股份有限公司 regarding the use of idle self-owned funds for cash management. It details the investment types, amounts, risk controls, and approvals by the board and supervisory committee. The document is a formal disclosure about a financial decision and authorization, not a financial report or earnings release. It does not contain financial statements or detailed financial data but rather informs shareholders and the market about the company's cash management plan and related board resolutions. This fits the category of a Capital/Financing Update (CAP), as it relates to the company's management of capital and investment of funds.
2023-08-21 Chinese
第五届监事会第三十二次（临时）会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 盈康生命科技股份有限公司 regarding the approval of a proposal to use idle funds for cash management. It includes details about the meeting, attendance, voting results, and references a related announcement published on a regulatory information website. The document is short (823 characters) and primarily serves as an official meeting resolution announcement rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2023-08-21 Chinese
关于变更保荐机构后重新签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the re-signing of a tripartite supervision agreement for the management and use of raised funds following a change in the company's sponsor institution. It details the background of the 2020 private placement, the signing of the new supervision agreement, and the current status of the special account for raised funds. The document does not contain financial statements or detailed financial performance data but rather focuses on regulatory compliance and procedural updates related to fundraising supervision. The document length is 2889 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Capital/Financing Update (CAP), as it relates to fundraising activities and the management of raised capital.
2023-08-11 Chinese
国泰君安关于盈康生命非公开发行股票限售股份上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal verification opinion from Guotai Junan Securities regarding the lifting of trading restrictions on shares issued in a 2020 non-public stock issuance by Yingkang Life Technology Co., Ltd. It details the share issuance, lock-up commitments, shareholding structure changes, and confirms compliance with relevant securities laws and regulations. The document is not a financial report, earnings release, or management discussion but rather a regulatory compliance and verification statement related to share circulation and lock-up release. It does not announce voting results, board changes, or capital raising but focuses on the lifting of share restrictions and the related regulatory review. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and verification filing that does not fit other specific categories like capital updates or share issue announcements. The document length is under 5,000 characters and contains detailed regulatory content rather than just an announcement, so it is not a Report Publication Announcement (RPA).
2023-07-25 Chinese
关于非公开发行股票限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement from 盈康生命科技股份有限公司 regarding the lifting of restrictions on certain shares issued in a 2020 non-public stock issuance. It details the number of shares becoming freely tradable, the shareholders involved, and the compliance with relevant securities laws and regulations. The document does not contain financial statements or detailed financial analysis but focuses on the change in share circulation status and stock listing details. It is a typical announcement about share restriction removal and share circulation changes, which fits the category of Share Issue/Capital Change (SHA). The document length is 2781 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is SHA with high confidence.
2023-07-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.